Lipid management guidelines--2001. National Heart ...[Med J Aust. 2001] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Med J Aust. 2001 Nov 5;175 Suppl:S57-85.Links

Lipid management guidelines--2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand.

National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand.

PMID: 11758552 [PubMed - indexed for MEDLINE]

Related articles

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
Heart Lung Circ. 2005 Dec; 14(4):275-91.

[Heart Lung Circ. 2005]
Review2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006.
Med J Aust. 2008 Mar 3; 188(5):302-3.

[Med J Aust. 2008]
Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.
Eur J Gen Pract. 2003 Mar; 9(1):16-24.

[Eur J Gen Pract. 2003]
[Lipid reduction--benefit without risk?]
Tidsskr Nor Laegeforen. 1997 Sep 20; 117(22):3184-5.

[Tidsskr Nor Laegeforen. 1997]
ReviewRecent trends in lipid management: raising the bar and shifting the goalposts?
Intern Med J. 2003 Mar; 33(3):95-102.

[Intern Med J. 2003]
» See reviews... | » See all...

Cited by 9 PubMed Central articles

Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).
Guymer RH, Dimitrov PN, Varsamidis M, Lim LL, Baird PN, Vingrys AJ, Robman L. Clin Interv Aging. 2008; 3(3):581-93.

[Clin Interv Aging. 2008]
A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics.
Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J, et al. Trials. 2008 Aug 6; 9:50. Epub 2008 Aug 6.

[Trials. 2008]
Adapting a Markov Monte Carlo simulation model for forecasting the number of coronary artery revascularisation procedures in an era of rapidly changing technology and policy.
Mannan HR, Knuiman M, Hobbs M. BMC Med Inform Decis Mak. 2008 Jun 25; 8:27. Epub 2008 Jun 25.

[BMC Med Inform Decis Mak. 2008]
» See all...

Recent Activity

Clear Turn Off Turn On

Lipid management guidelines--2001. National Heart Foundation of Australia, The Cardiac Soc...Lipid management guidelines--2001. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show